GlaxoSmithKline was among the talking points on Wednesday as the FTSE 100 broke its six-day winning streak.
The drugs company was once again linked with Human Genome Sciences, its US partner in the development of lupus drugs.
GSK seems to dismiss HGS rumour
By Bryce Elder and Neil Hume
Published: August 26 2009 08:48 | Last updated: August 26 2009 22:23
You have viewed your allowance of free articles. If you wish to view more, click the button below.
